Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CTX-8371 |
Trade Name | |
Synonyms | CTX 8371|CTX8371 |
Drug Descriptions |
CTX-8371 is a tetravalent bispecific antibody that targets CD274 (PD-L1) and PDCD1 (PD-1), potentially resulting in enhanced antitumor immune response and inhibition of tumor growth (PMID: 38379869). |
DrugClasses | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 121 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CTX-8371 | CTX-8371 | 0 | 1 |